In response to genotoxic stress, including UVB radiation, transcription factors NF-kB and p53 inevitably influence the cellular fate. Loss of p53 function has been attributed to malignant transformation and interferes with therapeutic interventions, whereas ''gain of function'' mutants even enhance tumor promotion. Constitutive NF-kB activation is linked to tumor maintenance and resistance against chemotherapy. The cross talk between p53 and NF-kB, however, is still under debate. Using the non-transformed keratinocyte cell line HaCaT, we shed light on the interplay between p53 and NF-kB by providing clear evidence that chronically activated NF-kB together with designated ''gain of function'' mutp53 promotes apoptosis via cooperative tumor necrosis factor (TNF) production in response to UVB þ IL-1. Performing chromatin immunoprecipitation analysis we demonstrate that both transcription factors bind to the TNF promoter, whereas UVB-induced inhibition of Ser-Thrphosphatase protein phosphatase 2A facilitates prolonged phosphorylation of NF-kB and the transcriptional cofactor cAMP response element-binding protein, both being required for extended TNF transcription. Thus, two major anti-apoptotic factors, NF-kB and mutp53, in concert may generate pro-apoptotic responses. As human skin is constantly exposed to UVB, causing IL-1 production as well, we hypothesize that the remarkable amount of hotspot p53 mutations within the epidermis (4%) may serve a protective function to eliminate precancerous cells at an early stage.
INTRODUCTION
In response to cellular stresses, the cross talk between pro-and anti-apoptotic factors determines the cellular fate. Whereas activation of the tumor-suppressor p53 causes upregulation of pro-apoptotic genes following genotoxic stress (Seitz et al., 2010) , activation of the transcription factor nuclear factor kB (NF-kB) is mainly associated with anti-apoptotic responses (Fujioka et al., 2012; Almeida et al., 2014) . Inactivation of p53 is observed in most human cancers, with mutations in p53 occurring in about 50% of all tumors (Soussi and Wiman, 2007) , reaching up to 90% in non-melanoma skin cancer (Gervin et al., 2003) . Intriguingly, in addition to ''loss of function'' mutants that lack the tumor-suppressive function, ''gain of function'' mutp53 variants lose the sequence-specific DNA binding but exert complex DNA interactions instead, thereby modifying the set of target genes expressed (Goehler et al., 2005; Kim and Deppert, 2007) . Accordingly, contact (p53R248W) and structural (p53R175H) mutations are enabled in order to promote a large spectrum of cancer phenotypes and contribute to drug resistance (Moll et al., 2005; Deppert, 2007; Vousden and Lane, 2007) . In contrast to wtp53, both mutants were shown to confer a selective advantage during tumor development, although the individual mechanisms are still under debate (Mello and Attardi, 2013) .
NF-kB is mainly triggered in response to pro-inflammatory cytokines, including IL-1. Receptor-driven activation of a downstream kinase cascade involving IkB-kinase b (IKKb) causes proteasomal degradation of the inhibitor of kBa (IkBa), allowing for nuclear translocation of NF-kB. Because constitutive activation of NF-kB has been linked to transformation, proliferation, and anti-apoptosis (Aggarwal, 2004) , limitation of its activity is warranted by negative feedback regulation involving NF-kB-dependent transcription of IkBa (Delhase et al., 1999) . More recently, increasing evidence has been found that additionally attribute pro-apoptotic functions to NF-kB when exposed to DNA-damaging agents (Delhase et al., 1999; Campbell et al., 2004; Liu et al., 2006; Szoltysek et al., 2008; O'Prey et al., 2010; Narayanan et al., 2014) . Accordingly, previous work from our lab showed co-stimulation with IL-1 to enhance UVB-induced apoptosis in epithelial cells by accelerated NF-kB-dependent transcription of tumor necrosis factor (TNF). Released TNF triggered TNF-R1 in an autocrine manner to additively promote apoptosis (Poppelmann et al., 2005; Strozyk et al., 2006; Barisic et al., 2008; Witt et al., 2009; Barisic et al., 2010) .
A versatile cross talk between p53 and NF-kB seems to exist especially in tumor cells, whereas in most cases mutual inhibition has been proposed (Webster and Perkins, 1999; Tergaonkar et al., 2002; Bohuslav et al., 2004; Tergaonkar, 2009) . Also the competition of both transcription factors for identical cofactors like CREB (cAMP response elementbinding protein) was shown to limit the relative activation status of p53 versus NF-kB (Webster and Perkins, 1999; Ikeda et al., 2000; Huang et al., 2007; Zschiedrich et al., 2008; Tergaonkar, 2009; Spooren et al., 2010) . In contrast, other reports attribute a cooperative role to wtp53 and NF-kB in apoptosis induction through mutual activation (Ryan et al., 2000) , collaborative promoter binding (Ma et al., 2008) , or direct protein-protein interaction (Schneider et al., 2010) . Less, however, is known about the interplay between ''gain of function'' mutp53 and NF-kB in response to genotoxic stress.
Utilizing the non-transformed keratinocyte cell line HaCaT stably knocked down for p53 and/or stably inhibiting NF-kB activation, we demonstrate that mutp53R248W and mutp53R175H but not wtp53 cooperate with NF-kB through direct binding to the TNF promoter. Consequently, accelerated TNF production enhances apoptosis in response to UVB þ IL-1. We further provide evidence that UVB-induced inhibition of Ser-Thr-phosphatase protein phosphatase 2A (PP2A) plays a crucial role in sustaining phosphorylation of NF-kB-p65 and CREB to maintain both factors in an active state over time. Hence, we report that two initially antiapoptotic factors, which are commonly present in various cancers, in concert may promote pro-apoptotic responses.
RESULTS

Co-stimulation with IL-1 enhances UVB-induced apoptosis in an NF-jB-dependent manner
In accordance with previous findings (Poppelmann et al., 2005; Strozyk et al., 2006; Barisic et al., 2008) , co-stimulation of HaCaT keratinocytes with IL-1 significantly enhanced UVBinduced apoptosis ( Figure 1a ). As this enhancement could be blocked with an antagonistic TNF-R1 antibody, TNF-dependent TNF-R1 activation seemed to affirm the underlying mechanism as reported before (Poppelmann et al., 2005; Barisic et al., 2008) . Thus, enhancement of apoptosis was also evident by pronounced processing of caspase-3 and poly(ADP-ribose)polymerase (PARP) ( Figure 1b ) and coincided with considerable TNF release ( Figure 1c ). Similar to epithelial cells, TNF production in keratinocytes could be attributed to disruption of the negative feedback regulation of NF-kB: IL-1 stimulation caused transient NF-kB activation with maximum degradation of IkBa after 30 minutes ( Figure 1d ). Rapid NF-kB-dependent resynthesis entailed replenishment of IkBa after 1-2 hours, which terminated nuclear NF-kB activity. In contrast, co-stimulation with UVB þ IL-1 completely abrogated the reappearance of IkBa up to 6 hours, coinciding with elevated nuclear NF-kB level (Figure 1d ). Consequently, prolonged transcription of TNF was facilitated upon UVB þ IL-1 treatment (Figure 1e ), being a prerequisite for enhanced TNF secretion (Barisic et al., 2008) . The notion that inhibition of negative feedback regulation drives NF-kB-dependent TNF production was confirmed in HaCaT cells stably overexpressing an IkBa super-repressor (IkBa-SR; Figure 1f ). Overall, apoptosis was slightly enhanced, but more importantly, the enhancing effect of IL-1 on UVB-induced apoptosis was abrogated ( Figure 1g ) because of significantly reduced TNF secretion ( Figure 1h ). Still, some residual TNF production remained, indicating that additional factors might contribute to elevated TNF production.
The intensity of DNA damage correlates with the apoptosis rate induced and the amount of TNF released Irradiation of cells with increasing doses of UVB caused gradual enhancement of apoptosis (Figure 2a ), which correlated with increasing amounts of cyclobutane-pyrimidine dimer formation (Figure 2c ). At a constant IL-1 level also the amount of TNF secretion gradually increased (Figure 2b ), implying a link between DNA damage and TNF production. Conclusively, we assumed an additional transcription factor to become activated in response to UVB-driven DNA damage that may cooperate with NF-kB for full TNF production in response to UVB þ IL-1.
p53 contributes to TNF-mediated enhancement of UVB-induced apoptosis
The transcription factor p53 plays a crucial role in mediating DNA damage responses. HaCaT cells are known to harbor mutated p53, carrying heterozygous C-T transitions (Lehman et al., 1993) , changing it into a ''gain of function''-like phenotype. As ''gain of function'' mutations of p53 are known to exert an anti-apoptotic phenotype, stable knockdown of p53 sensitized three different HaCaT-p53i clones to UVB-induced apoptosis (Figure 3a and b) , whereas the IL-1-mediated upregulation (n-fold) appeared to be impaired in HaCaT-p53i cells and also yielded less TNF (Figure 3d ). The protein level of other p53 family members, p63 and p73, remained unaffected by loss of p53 (Figure 3c ), indicating that solely p53 might contribute to accelerated apoptosis and TNF production in response to UVB þ IL-1. Accordingly, additional inhibition of NF-kB by stably overexpressing IkBa-SR in HaCaT-p53i cells (Figure 3e ) minimized both, apoptosis enhancement ( Figure 3f ) and TNF release (Figure 3g ). Conclusively, data implied that both transcription factors may collectively amplify the pro-apoptotic effect in UVB þ IL-1treated cells.
NF-jB and p53 additively promote TNF transcription in response to UVB þ IL-1 Activation of the NF-kB subunit p65 is facilitated by Ser536 phosphorylation, whereas Ser15 phosphorylation is required for p53 activation (Graham and Gibson, 2005; Ray et al., 2012) . Treatment of HaCaT cells with IL-1 caused transient phosphorylation of p65, being terminated after 2 hours, the time point of IkBa resynthesis. Phosphorylation of the transcriptional coactivator CREB at Ser133 (Friedrich et al., 2010) followed the identical pattern, indicating that both proteins are required for proper IL-1-induced transcription. The DNA damage-responsive transcription factor p53 remained inactive following IL-1 stimulation, as anticipated. In response to UVB, instead, p65 stayed inactive, whereas phosphorylation of p53 rapidly occurred and lasted for at least 4 hours. Activation of p53 also coincided with CREB phosphorylation, confirming CREB to be an important cofactor for both transcription factors (Huang et al., 2007) . Finally, co-stimulation with UVB þ IL-1 allowed phosphorylation of all three components. Whereas the phosphorylation pattern of p53 and CREB remained unchanged compared with UVB-treated cells, p65 phosphorylation was extended (Figure 4a ; (Barisic et al., 2008) ). Interestingly, knockdown of p53 did not influence the phosphorylation pattern of p65 and CREB (Figure 4b ), implying that NF-kB and p53 act additively but independently to enhance TNF transcription. In accordance with this assumption, co-immunoprecipitation revealed that p65 and p53 do not directly interact at the protein level (Figure 4c and d) .
From previous studies, we knew that UVB-mediated inhibition of catalytic subunit of PP2A (PP2Ac) crucially contributes to abrogation of negative feedback regulation for NF-kB through chronic IKKb activation (Barisic et al., 2008 (Barisic et al., , 2010 . We here discover an additional role for PP2A in tuning NF-kB activity. In control cells, only treatment with UVB þ IL-1 caused p65 phosphorylation, whereas p53 and CREB were activated by UVB and UVB þ IL-1, respectively. Inhibition of PP2Ac by small interfering RNA-mediated knockdown and addition of calyculin A had no effect on p53 phosphorylation but significantly stabilized phosphorylation of p65 and CREB (Figure 4e ). These results disclose two ways of PP2A-mediated NF-kB regulation: indirectly by dephosphorylating IKKb to terminate nuclear localization of NF-kB and directly by dephosphorylating p65 and CREB to terminate transcription (Figure 4f ). Activation of p53, instead, is exclusively driven in a DNA damage-responsive manner and remains unaffected by PP2A.
Only mutp53 but not wtp53 binds to the TNF promoter to enhance NF-jB-driven TNF transcription According to our findings so far, we assumed that p65 and p53 may cooperatively bind to the TNF promoter in response to UVB þ IL-1. This idea was strengthened by the finding that, besides p65 and CREB consensus elements, a putative (partial) p53 binding motive also exists within the TNF promoter sequence ( (Kuo and Leiden, 1999) , Supplementary Figure S1 online). As expected, chromatin immunoprecipitation analysis of p65 consolidated the prolonged association of NF-kB with the TNF promoter in response to UVB þ IL-1 in semiquantitative ( Figure 5a ) and quantitative PCR analyses (Figure 5b) . In order to dissect the binding properties of different p53 variants, we overexpressed wtp53 as well as mutp53R248W and mutp53R175H in HaCaT-p53i cells (Figure 5c ). As assumed, endogenous mutp53 bound to the TNF promoter for at least 2 hours following UVB þ IL-1 treatment (Figure 5d semiquantitative and 5e quantitative). Interestingly, wtp53 was shown to hardly associate with the TNF promoter compared to mutp53R248W and mutp53R175H (Figure 5d and e). Taken together, binding of NF-kB and only ''gain of function'' mutp53 was significantly intensified over time, whereas binding of wtp53 was neglectable. Concordantly, we could identify different effects of wtp53 versus mutp53 expression on apoptosis as well as TNF release (Figure 5f and g) . IL-1mediated enhancement of UVB-induced apoptosis was stronger in cells harboring mutp53-i.e. normal HaCaT cells as well as mutp53R248W and mutp53R175H expressing HaCaT- p53i cells, and remained only marginal in HaCaT-p53i-and -wtp53-expressing cells (Figure 5f ). Of note, the apoptotic responses correlated well with the amount of TNF released by the individual cell lines. Data confirmed accelerated TNF release to closely correlate with pronounced enhancement of apoptosis and strengthens the view that this effect is most pronounced in mutp53-expressing cells (Figure 5g ).
Mutp53 prevents clonogenic outgrowth of UVB þ IL-1-treated cells Three weeks following UVB or UVB þ IL-1 stimulation, clonogenic outgrowth of HaCaT-mock compared with HaCaT-p53i cells was determined. Whereas cell density of UVB þ IL-1-treated HaCaT-p53i cells reached an average 89% compared with UVB-treated cells, only 77% cell density was achieved for HaCaT-mock cells (Figure 6a and b) . This supported the concept that cell survival might be impaired following UVB þ IL-1 treatment if p53 is mutated.
Taken together, we here disclose the cooperation of ''gain of function'' mutp53 and NF-kB at the TNF promoter and provide evidence that two initially anti-apoptotic proteins in concert may generate pro-apoptotic responses. resistance. A versatile cross talk between NF-kB and p53 exists at multiple levels; however, the balance between synergistic and antagonistic processes may rely on the cellular context. In the present study, we confirm the molecular mechanism by which chronic NF-kB activation contributes to enhancement of UVB-induced apoptosis via upregulation of TNF in keratinocytes (Poppelmann et al., 2005; Barisic et al., 2008) . Intriguingly, at a constant IL-1 concentration required for NF-kB activation, increasing UVB exposure linked TNF release to the intensity of DNA damage induced, pointing at p53 to support TNF transcription. Hence, TNF release and thereby IL-1-mediated enhancement of UVB-induced apoptosis was minimized in HaCaT-p53i-IkBa-SR cells.
DISCUSSION
Previous studies have described mutp53 to augment TNFinduced NF-kB activity (Weisz et al., 2007) or have shown that NF-kB-p65 is required for TNF-induced upregulation of p53 target genes in different mouse tissues (Wang et al., 2009; O'Prey et al., 2010) . However, a collaboration of the two transcription factors at the human TNF promoter has never been reported. Even though NF-kB-p53 protein-protein interactions have been proposed at responsive promoter elements (Gurzov et al., 2010) or at NF-kB-responsive reporter constructs (Kawauchi et al., 2008) , we could not coimmunoprecipitate p53 and p65 in UVB þ IL-1-exposed cells. This indicates that both factors independently but additively trigger the TNF promoter. The activation kinetics for p65, p53, and the joint coactivator CREB clearly showed UVB to activate p53 and also to extend IL-1-induced activation for p65 and CREB. Although p53 phosphorylation follows an established ataxia telangiectasia mutateddependent (ATM) mechanism (Zhang et al., 2011) , we here deciphered a PP2A-dependent mechanism that drives prolonged p65 and CREB phosphorylation. On the basis of current and former data, we propose the following scenario to underlie activation of p53 and hyperactivation of NF-kB at the TNF promoter.
IL-1 causes canonical activation of NF-kB, whereas UVB activates p53. In parallel, UVB-induced inhibition of PP2Ac allows for nuclear persistence of NF-kB (Barisic et al., 2008; Witt et al., 2009; Barisic et al., 2010; Zhang et al., 2011; Konrath et al., 2014) and warrants prolonged activation of p65 and CREB. The fact that NF-kB activity still vanishes at later times point can be attributed to other IkB members, such as IkBe, that take over NF-kB inhibition in a delayed and more linear manner (Hoffmann et al., 2002) .
Thus, the present study is of high patho-/physiological relevance, because IL-1 is constantly produced from UVBexposed keratinocytes within human skin (Feldmeyer et al., 2007) . UVB radiation may serve as a carcinogen by activation of skin oncogenes, inactivation of tumor suppressors, and repression of cell-based immune responses that are generally able to eliminate highly antigenic skin tumors (Yarosh and Kripke, 1996) . At the same time, UVB-induced DNA damage is a prerequisite for execution of apoptosis, leading to elimination of cancer-prone cells (Kulms and Schwarz, 2000; Murphy et al., 2001) . The molecular switch, however, has not yet been identified. As p53 carries hotspots for UVB-induced mutations, numerous studies exist postulating 4% of all keratinocytes to bare p53 mutations; however, less squamous cell carcinoma develop (Murphy et al., 2001; Klein et al., 2010) . It is further common knowledge that up to 50% of all tumors and up to 90% of non-melanoma skin cancers bear p53 mutations (Murphy et al., 2001; Gervin et al., 2003) , clearly supporting that mutp53 selectively promotes tumor progression once the oncogenic pressure exceeds a certain threshold. Still, we hypothesize that at sub-oncogenic stresses and concomitant IL-1 production, provided e.g. by keratinocytes from the microenvironment, expression of mutp53 may even be beneficial for mildly damaged cancer-prone cells to enforce their elimination via TNF-dependent apoptosis.
In addition, the present study sheds light on the ongoing discussions about the p53-NF-kB interplay in cancer and may have even broader implications regarding cancer treatment, where currently a lot of effort is made to reconstitute wtp53 and/or inhibit NF-kB in cancer cells (Lin and Karin, 2003; Muller and Vousden, 2013) .
MATERIALS AND METHODS
Results of quantitative PCR, Cell Death Detection-, and TNF-ELISA are presented as mean±SD of three independently performed experiments. Reverse transcriptase-PCR, electrophoretic mobility shift assay, and western blot analyses represent one out of three independently performed experiments. For statistical analysis, Student's t-test was performed.
Cells and reagents
The human keratinocyte cell line HaCaT (Fusenig et al., 1990) was cultured in DMEM, 10% fetal calf serum, and 1% PenStrep (Thermo Scientific, Waltham, MA) and irradiated with UVB (300 J m À 2 ) using TL12 fluorescent bulbs (290-320 nm, Philips; Eindthoven, the Netherlands) or stimulated with recombinant human IL-1b (10 ng ml À 1 ) or TNF (100 ng ml À 1 ; both R&D Systems, Minneapolis, MN). TNF-R1 was blocked with an antagonistic antibody H-398 (40 mg ml À 1 ) kindly provided by Dr Peter Scheurich, University of 
